1. Home
  2. OC vs UTHR Comparison

OC vs UTHR Comparison

Compare OC & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OC
  • UTHR
  • Stock Information
  • Founded
  • OC 1938
  • UTHR 1996
  • Country
  • OC United States
  • UTHR United States
  • Employees
  • OC N/A
  • UTHR N/A
  • Industry
  • OC Industrial Machinery/Components
  • UTHR Biotechnology: Pharmaceutical Preparations
  • Sector
  • OC Industrials
  • UTHR Health Care
  • Exchange
  • OC Nasdaq
  • UTHR Nasdaq
  • Market Cap
  • OC 16.9B
  • UTHR 16.1B
  • IPO Year
  • OC N/A
  • UTHR 1999
  • Fundamental
  • Price
  • OC $182.61
  • UTHR $358.93
  • Analyst Decision
  • OC Buy
  • UTHR Buy
  • Analyst Count
  • OC 13
  • UTHR 14
  • Target Price
  • OC $201.75
  • UTHR $378.36
  • AVG Volume (30 Days)
  • OC 858.9K
  • UTHR 301.3K
  • Earning Date
  • OC 02-12-2025
  • UTHR 02-19-2025
  • Dividend Yield
  • OC 1.51%
  • UTHR N/A
  • EPS Growth
  • OC N/A
  • UTHR 25.10
  • EPS
  • OC 11.72
  • UTHR 22.72
  • Revenue
  • OC $10,439,000,000.00
  • UTHR $2,756,200,000.00
  • Revenue This Year
  • OC $16.54
  • UTHR $26.19
  • Revenue Next Year
  • OC $8.81
  • UTHR $10.79
  • P/E Ratio
  • OC $15.59
  • UTHR $15.80
  • Revenue Growth
  • OC 8.09
  • UTHR 25.04
  • 52 Week Low
  • OC $138.70
  • UTHR $208.62
  • 52 Week High
  • OC $214.53
  • UTHR $417.82
  • Technical
  • Relative Strength Index (RSI)
  • OC 56.67
  • UTHR 45.95
  • Support Level
  • OC $177.58
  • UTHR $357.55
  • Resistance Level
  • OC $183.96
  • UTHR $370.48
  • Average True Range (ATR)
  • OC 4.05
  • UTHR 8.55
  • MACD
  • OC 2.05
  • UTHR 0.60
  • Stochastic Oscillator
  • OC 93.25
  • UTHR 37.37

About OC Owens Corning Inc New

Owens-Corning Inc is a manufacturer of glass fiber utilized in composites and building materials. It has an integrated business model with three reportable segments: Composites, Insulation, and Roofing. It generates maximum revenue from the Roofing segment. Its Roofing segment laminate and strip asphalt roofing shingles, roofing components, synthetic packaging materials, and oxidized asphalt. It meets the growing demand for longer-lasting, aesthetically attractive laminate products with modest capital investment. Geographically the company generates the majority of its revenue from the United States.

About UTHR United Therapeutics Corporation

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

Share on Social Networks: